The Centers for Disease Control and Prevention updated its COVID vaccine guidance for immunocompromised people, making them eligible to receive a booster dose of a COVID vaccine at least six months after completing their primary vaccination series, which included a third dose.
Immunocompromised adults who received a third dose of either the Pfizer-BioNTech or Moderna COVID vaccine will become eligible for a fourth booster shot six months after receiving their third dose, according to the Centers for Disease Control and Prevention (CDC).
The CDC quietly updated its COVID vaccine guidance Monday for immunocompromised people.
“In such situations, people who are moderately and severely immunocompromised may receive a total of four vaccine doses,” with the fourth coming at least six months after the third, the CDC’s new guidelines said.
In August, the CDC authorized a third dose of either Pfizer-BioNTech or the Moderna mRNA vaccine — but not Johnson and Johnson’s (J&J) adenovirus vaccine — for certain immunocompromised people 18 and older. However, a third dose is now considered part of the primary series, rather than a booster.